Status:
NOT_YET_RECRUITING
Combined Antagonistic Muscle Magnetic Stimulation and Selective Periferal Neurotomy to Improve Results on Spasticity
Lead Sponsor:
Juan Carlos M. Andreani MD
Conditions:
STROKE
Eligibility:
All Genders
25+ years
Phase:
NA
Brief Summary
The objective of the present trial is to demonstrate Magnetic stimulation as an useful complementary treatment in order to improve patients' evolution without the need of extensive surgical lesion.
Detailed Description
Patients with refractory post stroke upper right limb spasticity will operated by Median nerve or Median/ Cubital selective neurotomy depending upon more affected territories. Some of them could be a...
Eligibility Criteria
Inclusion
- Severe and refractory right Hemiparesia or Hemiplegia, affecting hand function.
- Failure of kinesic treatment
- 2 points or more Improvement on Modified Ashworth Scale after anestethic blockade
Exclusion
- Severe cardiovascular disease
- Severe pulmonary disease
- Neoplasia advanced disease
- Joint anchylosis
- Irreversible retraction for muscle fibrosis
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02226432
Start Date
March 1 2025
End Date
March 1 2027
Last Update
August 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.